AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Change-In-Other-Working-Capital" stands at -3.46 Billion United States Dollars for the trailing twelve months (TTM) period ending 09/30/2023, the highest value since 09/30/2022.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.54 Billion United States Dollars compared to the value the year prior.
The 1 year change is 1.54 Billion United States Dollars.
The 3 year change is -8.10 Billion United States Dollars.
The 5 year change is -4.53 Billion United States Dollars.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change In Other Working Capital | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change In Other Working Capital | 486,508,953,600.00 |
![]() | AbbVie Inc - Change In Other Working Capital | 399,570,305,024.00 |
![]() | Roche Holding AG - Change In Other Working Capital | 317,433,206,677.55 |
![]() | Novartis AG - Change In Other Working Capital | 255,096,620,580.91 |